MoonLake Immunotherapeutics - MLTX

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Apr 02, 2026 S D 248,530.0 16.79 4,172,818.7 1,039,238.0 View
Apr 02, 2026 S D 1,569,116.0 16.79 26,345,457.64 6,599,722.0 View
Apr 02, 2026 S D 1,932,354.0 16.79 32,444,223.66 8,302,735.0 View
Jan 09, 2026 Chief Executive Officer A A 520,342.0 0.0 0.0 520,342.0 View
Jan 09, 2026 Chief Financial Officer A A 354,296.0 0.0 0.0 1,276,305.0 View
Jan 09, 2026 Chief Scientific Officer A A 520,342.0 0.0 0.0 520,342.0 View
Dec 22, 2025 Chief Executive Officer C D 5,836.0 0.0 View
Dec 22, 2025 Chief Executive Officer D D 196,316.0 0.0 View
Dec 22, 2025 Chief Executive Officer C A 196,316.0 3,074,893.0 View
Dec 22, 2025 Chief Financial Officer C D 8,754.0 0.0 View
Dec 22, 2025 Chief Financial Officer D D 294,473.0 0.0 View
Dec 22, 2025 Chief Financial Officer C A 294,473.0 922,009.0 View
Dec 22, 2025 Chief Scientific Officer C D 1,052.0 0.0 View
Dec 22, 2025 Chief Scientific Officer D D 35,389.0 0.0 View
Dec 22, 2025 Chief Scientific Officer C A 35,389.0 35,389.0 View
Dec 10, 2025 Chief Executive Officer S D 70,000.0 14.49 1,014,300.0 2,878,577.0 View
Dec 10, 2025 Chief Executive Officer S D 130,000.0 15.08 1,960,400.0 2,948,577.0 View
Dec 10, 2025 Chief Scientific Officer S D 72,908.0 14.43 1,052,062.44 0.0 View
Dec 10, 2025 Chief Scientific Officer S D 130,000.0 15.08 1,960,400.0 72,908.0 View